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Little is known about whether and how two chronic diseases interact with each other inmodifying the risk of physical inactivity.The
aim of the present study is to identify chronic disease pairs that are associated with compliance or noncompliance with the Dutch
PA guideline recommendation and to study whether specific chronic disease pairs indicate an extra effect on top of the effects of
the diseases individually. Cross-sectional data from 3,386 participants of cohort study SMILE were used and logistic regression
analysis was performed to study the joint effect of the two diseases of each chronic disease pair for compliance with the Dutch PA
guideline. For six chronic disease pairs, patients suffering from both diseases belonging to these disease pairs in question show a
higher probability of noncompliance to the Dutch PA guideline, compared to what one would expect based on the effects of each
of the two diseases alone. These six chronic disease pairs were chronic respiratory disease and severe back problems; migraine and
inflammatory joint disease; chronic respiratory disease and severe kidney disease; chronic respiratory disease and inflammatory
joint disease; inflammatory joint disease and rheumatoid arthritis; and rheumatoid arthritis and osteoarthritis of the knees, hips,
and hands.
1. Introduction
Inspired by Health 2020 [1], the first World Health Orga-
nization (WHO) strategy to tackle physical inactivity in
the European Region from 2016 to 2025 was released last
September.The aim of this strategy is to inspire governments
and stakeholders to promote physical activity (PA) levels
among all citizens in the European Region. The rationale
for this effort was that health care systems are at risk of
being inundated by large numbers of people suffering the
effects of physical inactivity and sedentary behaviour, such
as coronary heart disease, hypertension, colon cancer, and
diabetesmellitus [2]. Suffering fromadisease is a risk factor in
the downward spiral of PA, especially among those suffering
from more than one chronic disease [3, 4].
To date, most studies that investigated the association
between chronic disease and PA are limited to one chronic
disease in particular, thus avoiding the actual complexity
[5–8]. From previous literature we know that patients with
chronic diseases and/or multimorbidity are at risk for phys-
ical inactivity [1–4]. For clinicians and physical therapists
it is particularly important to identify patients with specific
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combinations of chronic diseases that are at risk for extra
physical inactivity, so that more conscious approaches to
initiate or increase physical activity in these patients can be
applied. Although most chronic diseases are associated with
physical inactivity, little is known about whether two chronic
diseases might interact with each other in modifying the risk
of physical inactivity. Since the effect of two chronic diseases
on physical inactivity might not always be simply additive
it is important to highlight those chronic disease pairs for
whom the effect of both diseases on physical inactivity is
greater than the sum of the individual effects alone. Ourmain
research interest was to investigate whether certain disease
pairs/combinations indicate an “extra” additional effect, on
top of the effects of the diseases separately/individually. We
hypothesized that exposure to a specific combination of
chronic diseases had additional/extra (interaction) effects on
the risk of inadequate physical activity levels above what
would be expected from either exposure alone.
The present study has two aims, based on the observation
that chronic disease pairs provide information about how
combinations of diseases behave and how they may be
associated with PA.The first aim is to identify chronic disease
pairs that are associated with compliance or noncompliance
with the Dutch PA guideline recommendation and the
second is to investigate whether specific chronic disease pairs
indicate an additional/extra (interaction) effect on top of the
diseases separately/individually. A portion of the data from
the large prospective cohort Study of Medical Information
and Lifestyles in Eindhoven (SMILE), Netherlands, was used
for the present study [9].
2. Method
2.1. Study Design and Setting. The present study used a por-
tion of the data from the prospective dynamic cohort SMILE,
Netherlands [9]. The SMILE study focuses on different
aspects of disease, health, and lifestyle and is a joint project
between Maastricht University and 23 general practitioners
from nine primary health care centers of the Eindhoven Cor-
poration of Primary Health Care Centers (Stichting Gezond-
heidscentra Eindhoven (SGE)) in Eindhoven. The SMILE
cohort study was conducted between 2002 and 2010. One
goal of SMILE is to study diseases and their consequences.
In the SMILE cohort study two data collection strategies
were combined. With the help of electronic medical records
(EMRs), data on morbidity, mortality, medication, and care
facility utilisation were registered. Information on lifestyle
and chronic diseases was gathered on the basis of patient
questionnaires which were self-administered and completed
on paper. Detailed information on the study protocol can
be found in a publication by van den Akker et al. [9].
The SMILE protocol was approved by the medical ethics
committee of the Academic Hospital Maastricht (MEC 07-
04-030) and all participants signed written informed consent
forms [9].This paper was written according to STrengthening
the Reporting of OBservational Studies in Epidemiology
(STROBE) checklist for cohort studies in order to enhance
transparency and reproducibility.
2.2. Participants. Data of adult patients aged 55 from 2003
were used, as the numbers of patients who returned their
information on chronic diseases andPAbehaviour (𝑛=3,386)
were largest for that cohort year.
2.3. Data Sources/Measurement. All participants completed
two questionnaires. Information on chronic diseases was
measured using a self-reported chronic disease questionnaire
[10] which was distributed and returned in May 2003.
Physical activity behaviour was measured using the Short
Questionnaire to Assess Health-Enhancing Physical Activity
(SQUASH) [11]. Data from the SQUASH was gathered in
November 2003.
2.3.1. Self-Reported Chronic Disease Questionnaire. Informa-
tion about the presence/absence of chronic disease was
obtained from the self-reported chronic disease question-
naire, for which the medical screening questionnaire of
the Dutch Association of General Practitioners (Landelijke
Huisartsen Vereniging (LHV)) served as a template [8].
Participants were asked to report whether they had any of
the following fifteen chronic diseases at that time: (1) chronic
respiratory disease; (2) cardiovascular disease; (3) severe
bowel disease; (4) liver disease; (5) severe kidney disease; (6)
diabetes mellitus; (7) cancer; (8) epilepsy; (9) migraine; (10)
neurological disorders and stroke; (11) inflammatory joint
disease; (12) rheumatoid arthritis; (13) osteoarthritis of the
knees, hips, and hands; (14) severe back problems; and (15)
persistent injuries due to accidents. Furthermore, in response
to an open question, patients could report other diseases
they had which were not listed in the questionnaire. The
chronic diseases mentioned in response to this open question
(𝑁 = 1,077) were integrated into the questionnaire data. Two
researchers (SD and IM) and one medical specialist (JT)
independently assigned each disease to the existing categories
of the chronic disease questionnaire.
2.3.2. ShortQuestionnaire toAssessHealth-Enhancing Physical
Activity (SQUASH). The SQUASH was used to measure PA
[11]. This questionnaire asked about three main items: (1)
how many days per week one was active, (2) average time
of activity per day, and (3) PA intensity. Therefore it was
possible to assess compliance with the Dutch PA guideline
with this questionnaire. Participants were asked to report
their level of PA during an average week over the past
few months. To simplify reporting, the questionnaire was
subdivided into (a) commuting activities, (b) leisure time
activities, (c) household activities, and (d) activities at work
and at school. Using the Ainsworth compendium for physical
activities, a MET value was assigned to each activity [12, 13].
Activities between 1.6 and 2.9 METs were classified as light-
intense, activities between 3.0 and 5.9 METs as moderate-
intense, and activities ≥ 6 METs as vigorous-intense [13].
To determine compliance to the Dutch PA guideline, the
frequency, duration, and intensity of each activity were
multiplied by each other.
2.4. Variables. Chronic disease pairs were used as an inde-
pendent variable. Disease pairs were constructed based on
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105 possible chronic disease pairs
52 chronic disease pairs
Pearson’s Chi-square test
14 chronic disease pairs
15 chronic diseases indicated in
self-reported chronic
disease questionnaire
Excluded: nonsignificant
disease pairs 
Excluded: disease
pairs with N ≤ 10
Figure 1: Flowchart of the selection of chronic disease pairs.
the fifteen chronic diseases listed in the self-reported chronic
disease questionnaire. All possible combinations of two
chronic diseases were established. The primary outcome was
compliance with the Dutch PA guideline (0 = compliance
with the guideline and 1 = lack of compliance with the guide-
line).This guideline states that all adults should participate in
a total of at least 30 minutes of moderate-intense PA at least
five days a week, but preferably daily [14].
2.5. Bias. Of the 15 chronic diseases listed in the self-reported
chronic diseases questionnaire, missing values amounting
to some 17.5% to 24.2% were detected. The format of the
questionnaire was dichotomous and prestructured (yes/no).
The hypothesis is that a proportion of respondents followed
these instructions to the letter and only indicated the diseases
they hadwithout explicitly indicatingwhich ones they did not
suffer from (i.e., by ticking “no”).Therefore, allmissing values
were recorded as “disease being absent.”
2.6. Statistical Analysis. First, from the fifteen chronic dis-
eases listed in the self-reported chronic disease questionnaire,
a number of 105 (𝑁 ∗ [(𝑁 − 1)/2]) disease pairs (disease
A + disease B) were calculated (Table 5). The occurrence of
diseases pairs was calculated and pairs that affected fewer
than 10 participants were excluded from the analysis in order
to maximise the chance of showing an association with
compliance to the Dutch PA guideline. Pearson’s Chi-square
test was used to test whether patients having the combination
of two diseases show higher probabilities of noncompliance
compared to the other patients. The alpha was set at <0.10
to give room for the detection of all chronic disease pairs
associated with PA thatmight be relevant for clinical practice.
For all cross tables with a value 𝑁 ≤ 5 in at least one of
the cells, Fisher’s exact test was used as alternative for the
Chi-square [15]. Significant chronic disease pairs were listed
and were the subject of further analysis (𝑁 = 14; Figure 1).
The second aim of the present study was to study
whether the association between chronic disease pairs and
PA guideline compliance surpasses the expected result of
the combined effects of both diseases individually. Logistic
regression analyses were performed to study the joint effect of
the two diseases of each chronic disease pair for compliance
with the Dutch PA guideline. Compliance with the Dutch
PA guideline (1 = lack of compliance with the guideline;
0 = compliance with the guideline) was used as a dependent
variable. Independent variables included the two indicator
variables that represent occurrence of the two diseases of the
pair as well as the product of these two indicator variables in
order to capture a potential interaction effect. Main effects of
each disease separately/individually are not presented but can
be read from the model: the simple main effect of A (in terms
of an odds ratio) for B = 1 is equal to exp(coefficient of A) ∗
exp(coefficient of the interaction term); the simple main
effect of B (in terms of an odds ratio) for A = 1 is equal
to exp(coefficient of 𝐵) ∗ exp(coefficient of the interaction
term). Chronic disease pairs significant at 𝑝 < 0.10 were
studied.
3. Results
3.1. Participants. In total 3,386 participants (52.9% female)
completed and returned the self-reported chronic disease
questionnaire and the SQUASH. The average age of respon-
dents was 67.5 years of age (range: 55–95 years). Forty-seven
percent of the participants did not suffer from any chronic
disease, while 28%, 14%, 7%, 3%, and 1% reported having
one, two, three, four, and five chronic diseases, respectively
(Table 1).
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Table 1: Participant characteristics.
Characteristica Participants (𝑁 = 3,386)
Age (years) 67.5 ± 8.3
Sex (𝑁, % female) 1791 (52.9)
Height (cm) 170.0 ± 8.8
Body weight (kg) 75.1 ± 13.8
Osteoarthritis of knees, hips, or hands 780 (23.0)
Severe back problems 517 (15.3)
Chronic respiratory disease 321 (9.5)
Inflammatory joint disease 302 (8.9)
Cardiovascular disease 299 (8.8)
Diabetes mellitus 230 (6.8)
Migraine 158 (4.7)
Rheumatoid arthritis 150 (4.4)
Persistent injury due to an accident 132 (3.9)
Severe bowel disease 112 (3.3)
Cancer 77 (2.3)
Neurological disorders and stroke 70 (2.1)
Severe kidney disease 48 (1.4)
Epilepsy 20 (0.6)
Liver disease 16 (0.5)
aContinuous variables are presented as mean ± standard deviation and
dichotomous variables as𝑁 (%).
3.2. Selection of Chronic Disease Pairs. In total 105 possible
chronic disease pairs were assembled from the 15 chronic
diseases indicated in the self-reported chronic disease ques-
tionnaire (Tables 2 and 5). Fifty-three pairs were excluded
because ten or fewer participants suffered from them. The
most common chronic disease pair was “osteoarthritis of
knees, hips, and hands” and “severe back problems” (𝑁 =
259). Other chronic disease pairs affecting more than one
hundred participants were “inflammatory joint disease” and
“osteoarthritis of knees, hips, and hands” (𝑁 = 194); “chronic
respiratory disease” and “osteoarthritis of knees, hips, and
hands” (𝑁 = 114); and “inflammatory joint disease” and
“severe back problems” (𝑁 = 109).
For each of the 52 chronic disease pairs that were selected
for further study, it was tested whether patients having the
combination of the two diseases show higher probabilities
of noncompliance compared to the other patients. This was
the case for fourteen chronic disease pairs (Table 3). Chronic
respiratory disease seemed to cooccur in five of the pairs.
Cardiovascular disease, inflammatory joint disease, rheuma-
toid arthritis, and diabetes mellitus were part of four disease
pairs. Osteoarthritis of knees, hips, and hands emerged in
three disease pairs.The four remaining diseases forming part
of disease pairs were severe kidney disease, migraine, back
problems, and persistent injury due to an accident (Table 3).
3.3. Association between Chronic Disease Pairs and Lack of
Compliance with PA Guideline. Table 3 demonstrated that
these 14 chronic disease pairs are particularly interesting,
because patients suffering from both diseases of these pairs
show a higher probability of noncompliance to the PA
guideline compared to other patients.Therefore, we included
these 14 chronic disease pairs in the logistic regression
analysis. The results showed that the interaction term of
six chronic disease pairs was statistically significant, which
means that the effect of the two diseases combined is not
additive. Furthermore, in all six cases the odds ratio of
the interaction term is larger than one, which means that
patients suffering from both diseases of the pair in question
have an increased risk for noncompliance with the Dutch
PA guideline recommendation compared to what one would
expect based on the effects of each of the two diseases alone
(Table 4).
Patients who have the chronic disease pair chronic
respiratory disease and severe back problems have an even
higher risk for noncompliance to the Dutch PA guideline
recommendation than expected on the effect of the diseases
individually. The same was found for the chronic disease
pair migraine and inflammatory joint disease. Patients that
have both migraine and inflammatory joint disease have an
extra risk to show inadequate PA levels. Four other chronic
disease pairs were found to be particularly associated with
noncompliance with the PA guideline at a borderline signif-
icance level. Because they might still be relevant for clinical
practice we decided to present them, as well.The first chronic
disease pairwas chronic respiratory disease and severe kidney
disease. These patients have an extra risk of a lack of PA
guideline compliance. The same applies to patients who
suffered from chronic respiratory disease and inflammatory
joint disease simultaneously. Patients with the chronic disease
pair rheumatoid arthritis and inflammatory joint disease, as
well as rheumatoid arthritis and osteoarthritis of the knees,
hips, and hands also have an additional risk to not show
adequate PA behaviour (Table 4).
Figure 2 presents the percentage of participants with
disease A, disease B, and the chronic disease pair A and B
for whom the probability of noncompliance with the Dutch
PA guideline is larger than compared to what one would
expect from the effects of each of the two diseases alone.
Each disease pair consists of disease A and disease B. The
left and the right side of Figure 1 present the percentage of
noncompliance with the Dutch PA guideline for patients that
suffered from disease A only, but not from disease B (left
side), and for patients that suffered from disease B, but not
from disease A (right side). For example, of the patients who
had diabetes mellitus, but not rheumatoid arthritis, 34.9%
did not comply with the Dutch PA guideline (disease A, left
side). Of the patients who suffered from rheumatoid arthritis,
but not diabetes mellitus, 39.2% did not comply with the
Dutch PA guideline recommendation (disease B, right side).
Of all patients who suffered from the chronic disease pair
diabetesmellitus and rheumatoid arthritis (disease pairA+B,
middle), 69.2% did not comply with the Dutch PA guideline.
The strongest association of guideline noncompliance was
found in patients with the disease pair diabetes mellitus and
rheumatoid arthritis (percentage of noncompliance: 69.2%;
odds ratio: 3.652).
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Table 3: Chronic disease pairs inversely associated with PA guideline compliance.
Chronic disease pair 𝑁 Chi-square 𝑝 value
Cardiovascular disease and osteoarthritis of knees, hips, and hands 86 7.602 0.006
Diabetes mellitus and osteoarthritis of knees, hips, and hands 73 6.371 0.012
Chronic respiratory disease and inflammatory joint disease 40 5.714 0.018
Migraine and inflammatory joint disease 22 5.568 0.018
Inflammatory joint disease and rheumatoid arthritis 73 5.206 0.024
Diabetes mellitus and rheumatoid arthritis 13 4.953 0.026
Rheumatoid arthritis and osteoarthritis of knees, hips, and hands 87 4.882 0.028
Cardiovascular disease and inflammatory joint disease 40 4.262 0.040
Chronic respiratory disease and severe back problems 82 4.144 0.042
Chronic respiratory disease and severe kidney disease 10 4.004 0.098
Chronic respiratory disease and cardiovascular disease 47 3.938 0.048
Diabetes mellitus and persistent injury due to an accident 12 3.824 0.100
Chronic respiratory disease and rheumatoid arthritis 24 3.729 0.054
Cardiovascular disease and diabetes mellitus 37 3.482 0.062
Disease A Disease B
Disease pair
A and B
40.2%
34.9%
38.9%
40.6%
36.8%
41.8%
35.2%
39.2%
36.4%
39.7%
40.4%
31.6%70.0%
63.6%
57.5%
52.1%
50.6%
50.0%
Chronic respiratory disease
Chronic respiratory disease
Migraine
Chronic respiratory disease
Inflammatory joint disease
Rheumatoid arthritis
Severe kidney disease
Inflammatory joint disease
Inflammatory joint disease
Rheumatoid arthritis
Osteoarthritis
Severe back problems
40 35 30 25 20 15 10 5 045
Percentage of noncompliance to the Dutch PA 
guideline for patients with disease A
5 10 15 20 25 30 35 40 450
guideline for patients with disease B
Percentage of noncompliance to the Dutch PA Percentage of
Dutch PA guideline 
for patients with the 
disease pair A and B
noncompliance to the
Figure 2: Percentage of participants with disease A, disease B, and/or the disease pair A and B who did not comply with the Dutch physical
activity guideline.
4. Discussion
Six chronic disease pairs were shown to be particularly
interesting, because patients suffering from both diseases
belonging to these disease pairs in question show a higher
probability of noncompliance to the Dutch PA guideline,
compared to what one would expect based on the effects of
each of the two diseases alone.These six chronic disease pairs
were chronic respiratory disease and severe back problems;
migraine and inflammatory joint disease; chronic respira-
tory disease and severe kidney disease; chronic respiratory
disease and inflammatory joint disease; inflammatory joint
disease and rheumatoid arthritis; and rheumatoid arthritis
and osteoarthritis of the knees, hips, and hands.
Some limitations are worth mentioning. First, the pres-
ence or absence of chronic diseases was measured via self-
reported questionnaires. In the SMILE cohort study, infor-
mation on chronic diseases was also registered in EMRs;
however not all participants gave written consent to allow
comparing self-reported information with data registered in
the EMRs by general practitioners. Nevertheless, previous
research compared self-reported SMILE cohort data with
EMR information and revealed an agreement of over 80%
for most of the chronic diseases. This supports the use of
self-reported data to answer our research question [16]. Sec-
ondly, to preserve as much information as possible, missing
values in the self-reported chronic disease questionnaire
were interpreted as “absence of disease.” This may have led
BioMed Research International 7
Table 4: Association between chronic disease pairs and PA guideline compliance.
Disease 𝑁 Odds ratio
95% confidence interval
𝑝 value
Lower Upper
A Chronic respiratory disease 311 1.129 0.891 1.431 0.316
B Severe kidney disease 38 0.725 0.365 1.443 0.360
A and B Chronic respiratory disease and severe kidney disease 10 4.478 0.966 20.765 0.055+
A Migraine 136 0.910 0.637 1.300 0.605
B Inflammatory joint disease 280 1.059 0.825 1.360 0.651
A and B Migraine and inflammatory joint disease 22 2.841 1.078 7.486 0.035∗
A Chronic respiratory disease 281 1.081 0.842 1.388 0.542
B Inflammatory joint disease 262 1.042 0.805 1.350 1.042
A and B Chronic respiratory disease and inflammatory joint disease 40 1.902 0.927 3.902 0.080+
A Inflammatory joint disease 229 0.997 0.757 1.313 0.981
B Rheumatoid arthritis 77 0.896 0.560 1.434 0.647
A and B Inflammatory joint disease and rheumatoid arthritis 73 1.906 0.938 3.873 0.074+
A Rheumatoid arthritis 63 0.845 0.500 1.426 0.527
B Osteoarthritis of knees, hips, and hands 693 1.017 0.856 1.208 0.849
A and B Rheumatoid arthritis and osteoarthritis of knees, hips, and hands 87 1.875 0.942 3.735 0.074+
A Chronic respiratory disease 239 1.033 0.788 1.353 0.814
B Severe back problems 435 0.835 0.675 1.032 0.095
A and B Chronic respiratory disease and severe back problems 82 1.784 1.033 3.083 0.038∗
A Cardiovascular disease 213 1.247 0.940 1.656 0.126
B Osteoarthritis of knees, hips, and hands 694 1.025 0.862 1.219 0.780
A and B Cardiovascular disease and osteoarthritis of knees, hips, and hands 86 1.448 0.850 2.464 0.173
A Chronic respiratory disease 297 1.120 0.879 1.428 0.358
B Rheumatoid arthritis 126 1.114 0.775 1.600 0.560
A and B Chronic respiratory disease and rheumatoid arthritis 24 1.778 0.710 4.454 0.219
A Diabetes mellitus 217 1.638 1.243 2.159 0.000
B Rheumatoid arthritis 137 1.156 0.817 1.637 0.413
A and B Diabetes mellitus and rheumatoid arthritis 13 1.928 0.549 6.773 0.306
A Diabetes mellitus 218 1.647 1.251 2.169 0.000
B Persistent injury due to an accident 120 1.078 0.743 1.565 0.692
A and B Diabetes mellitus and persistent injury due to an accident 12 1.821 0.504 6.580 0.360
A Cardiovascular disease 259 1.327 1.027 1.715 0.030
B Inflammatory joint disease 262 1.077 0.832 1.395 0.572
A and B Cardiovascular disease and inflammatory joint disease 40 1.377 0.672 2.821 0.382
A Chronic respiratory disease 274 1.118 0.868 1.439 0.388
B Cardiovascular disease 252 1.336 1.030 1.731 0.029
A and B Chronic respiratory disease and cardiovascular disease 47 1.231 0.628 2.413 0.546
A Cardiovascular disease 262 1.379 1.069 1.779 0.013
B Diabetes mellitus 193 1.710 1.277 2.290 0.000
A and B Cardiovascular disease and diabetes mellitus 37 0.827 0.391 1.750 0.619
A Diabetes mellitus 157 1.651 1.195 2.282 0.002
B Osteoarthritis of knees, hips, and hands 707 1.050 0.885 1.247 0.575
A and B Diabetes mellitus and osteoarthritis of knees, hips, and hands 73 1.078 0.602 1.930 0.800
∗
𝑝 ≤ 0.005; +𝑝 ≤ 0.01.
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Table 5: All possible chronic disease pairs (𝑁 = 105).
Number Chronic disease pair
1 Chronic respiratory disease and cardiovascular disease
2 Chronic respiratory disease and severe bowel disease
3∗ Chronic respiratory disease and liver disease
4 Chronic respiratory disease and severe kidney disease
5 Chronic respiratory disease and diabetes mellitus
6 Chronic respiratory disease and cancer
7∗ Chronic respiratory disease and epilepsy
8 Chronic respiratory disease and migraine
9 Chronic respiratory disease and neurological disordersand stroke
10 Chronic respiratory disease and inflammatory jointdisease
11 Chronic respiratory disease and rheumatoid arthritis
12 Chronic respiratory disease and osteoarthritis of knees,hips, and hands
13 Chronic respiratory disease and severe back problems
14 Chronic respiratory disease and persistent injury due toan accident
15∗ Cardiovascular disease and severe bowel disease
16∗ Cardiovascular disease and liver disease
17∗ Cardiovascular disease and severe kidney disease
18 Cardiovascular disease and diabetes mellitus
19 Cardiovascular disease and cancer
20∗ Cardiovascular disease and epilepsy
21 Cardiovascular disease and migraine
22 Cardiovascular disease and neurological disorders andstroke
23 Cardiovascular disease and inflammatory joint disease
24 Cardiovascular disease and rheumatoid arthritis
25 Cardiovascular disease and osteoarthritis of knees, hips,and hands
26 Cardiovascular disease and severe back problems
27 Cardiovascular disease and persistent injury due to anaccident
28∗ Severe bowel disease and liver disease
29∗ Severe bowel disease and severe kidney disease
30∗ Severe bowel disease and diabetes mellitus
31∗ Severe bowel disease and cancer
32∗ Severe bowel disease and epilepsy
33 Severe bowel disease and migraine
34∗ Severe bowel disease and neurological disorders andstroke
35 Severe bowel disease and inflammatory joint disease
36∗ Severe bowel disease and rheumatoid arthritis
37 Severe bowel disease and osteoarthritis of knees, hips,and hands
38 Severe bowel disease and severe back problems
39∗ Severe bowel disease and persistent injury due to anaccident
40∗ Liver disease and severe kidney disease
Table 5: Continued.
Number Chronic disease pair
41∗ Liver disease and diabetes mellitus
42∗ Liver disease and cancer
43∗ Liver disease and epilepsy
44∗ Liver disease and migraine
45∗ Liver disease and neurological disorders and stroke
46∗ Liver disease and inflammatory joint disease
47∗ Liver disease and rheumatoid arthritis
48∗ Liver disease and osteoarthritis of knees, hips, and hands
49∗ Liver disease and severe back problems
50∗ Liver disease and persistent injury due to an accident
51∗ Severe kidney disease and diabetes mellitus
52∗ Severe kidney disease and cancer
53∗ Severe kidney disease and epilepsy
54∗ Severe kidney disease and migraine
55∗ Severe kidney disease and neurological disorders andstroke
56∗ Severe kidney disease and inflammatory joint disease
57∗ Severe kidney disease and rheumatoid arthritis
58 Severe kidney disease and osteoarthritis of knees, hips,and hands
59∗ Severe kidney disease and severe back problems
60∗ Severe kidney disease and persistent injury due to anaccident
61 Diabetes mellitus and cancer
62∗ Diabetes mellitus and epilepsy
63∗ Diabetes mellitus and migraine
64∗ Diabetes mellitus and neurological disorders and stroke
65 Diabetes mellitus and inflammatory joint disease
66 Diabetes mellitus and rheumatoid arthritis
67 Diabetes mellitus and osteoarthritis of knees, hips, andhands
68 Diabetes mellitus and severe back problems
69 Diabetes mellitus and persistent injury due to an accident
70∗ Cancer and epilepsy
71∗ Cancer and migraine
72∗ Cancer and neurological disorders and stroke
73 Cancer and inflammatory joint disease
74∗ Cancer and rheumatoid arthritis
75 Cancer and osteoarthritis of knees, hips, and hands
76 Cancer and severe back problems
77∗ Cancer and persistent injury due to an accident
78∗ Epilepsy and migraine
79∗ Epilepsy and neurological disorders and stroke
80∗ Epilepsy and inflammatory joint disease
81∗ Epilepsy and rheumatoid arthritis
82∗ Epilepsy and osteoarthritis of knees, hips, and hands
83∗ Epilepsy and severe back problems
84∗ Epilepsy and persistent injury due to an accident
85∗ Migraine and neurological disorders and stroke
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Table 5: Continued.
Number Chronic disease pair
86 Migraine and inflammatory joint disease
87 Migraine and rheumatoid arthritis
88 Migraine and osteoarthritis of knees, hips, and hands
89 Migraine and severe back problems
90 Migraine and persistent injury due to an accident
91 Neurological disorders and stroke and inflammatoryjoint disease
92∗ Neurological disorders and stroke and rheumatoidarthritis
93 Neurological disorders and stroke and osteoarthritis ofknees, hips, and hands
94 Neurological disorders and stroke and severe backproblems
95∗ Neurological disorders and stroke and persistent injurydue to an accident
96 Inflammatory joint disease and rheumatoid arthritis
97 Inflammatory joint disease and osteoarthritis of knees,hips, and hands
98 Inflammatory joint disease and severe back problems
99 Inflammatory joint disease and persistent injury due toan accident
100 Rheumatoid arthritis and osteoarthritis of knees, hips,and hands
101 Rheumatoid arthritis and severe back problems
102∗ Rheumatoid arthritis and persistent injury due to anaccident
103 Osteoarthritis of knees, hips, and hands and severe backproblems
104 Osteoarthritis of knees, hips, and hands and persistentinjury due to an accident
105 Severe back problems and persistent injury due to anaccident
∗DUOs excluded because𝑁 ≤ 10.
to an underestimation of the total disease burden of the
population. Thirdly, the self-reported chronic disease ques-
tionnaire provided information on fifteen chronic diseases
without severity assessment, which could be interpreted as a
limitation. Lastly, self-reported PA measurement could have
been influenced by social desirability and seasonal factors.
Previous research conducted by Sallis and Saelens [17] already
showed that people tend to overestimate their PA. To limit
this type of bias, participants were explicitly informed that
neither researchers nor their caregivers would receive any
information from the self-reported questionnaires.
An exceeded inverse association between the chronic
disease pair chronic respiratory disease and severe back
problems and Dutch PA guideline compliance was revealed.
This chronic disease pair might extra interfere with PA due
to the interrelated anatomical and physiological cohesive
structure of the thoracic cage, which is formed by the spine,
rib cage, and associatedmuscles, which are affected inmyriad
ways in patients with chronic respiratory disease and severe
back problems [18]. One of the main symptoms of chronic
respiratory disease, which was defined in the self-reported
disease questionnaire as chronic bronchitis, emphysema,
and asthma, is a hacking cough which may induce and
aggravate severe musculoskeletal back pain. Furthermore,
biochemical and neurological interactions between chronic
respiratory disease and severe back problems might under-
pin the exceeded inverse association between this chronic
disease pair and inadequate PA levels. A decrease in CO
2
together with an increase in pH inhibits the transfer from
haemoglobin of oxygen to tissue cells, which affects normal
muscular function, motor control, and pain perception [18].
Taken together, the strength of the interdependency between
chronic respiratory disease and severe back problems might
worsen the pain and decrease functional ability of patients
and thereby extra interfere with adequate PA behaviour.
Patients suffering from the chronic disease pair migraine
and inflammatory joint disease also showed extraordinary
inadequate PA levels. Previous research has shown that the
association between migraine and PA is two-sided. On the
one hand, PA has been shown to have a beneficial effect on
the frequency, intensity, and duration of migraine attacks and
patient well-being [19–21]. On the other hand, PA has been
shown to be a common trigger for headaches and migraine
attacks [22, 23]. Strenuous activities often cause dehydration,
higher body temperature, low blood sugar, and therefore
trigger migraine due to low blood oxygen levels [22]. Patients
with inflammatory joint disease experience persistent joint
pain and swelling of the joints due to the inflammatory
process, which can also occur during PA [24]. Being more
vigorous, strengthening exercises are often recommended for
patients with inflammatory joint disease because they are
designed to increase muscle strength. As the muscle becomes
stronger, it provides greater joint support and thereby reduces
stress and loading on the painful joint. Moreover, strong
muscles contribute to better functioning. Therefore, patients
that have both migraine and inflammatory joint disease may
display particularly inadequate PA levels, because they try to
avoid exercises that could trigger a migraine. When stiffness,
painful joints, and headaches are already bogging patients
down, the prospect of PA may seem overwhelming and
painful, causing them to limit their activity.
At the 10% significance level it was found that the asso-
ciation between the chronic disease pair chronic respiratory
disease and severe kidney disease with PA was exceedingly
reversed. Severe kidney disease generally refers to the pro-
gressive and irreversible loss of kidney function, in which in
themost severe stage renal replacement therapy in the formof
either dialysis or kidney transplantation becomes necessary
in order to keep the patient alive and maintain quality
of life [25]. Physical activity levels in patients with severe
kidney disease are usually low [26, 27]. Additionally, these
patients report lower physical functioning and performance
than those with normal kidney function [26]. Literature has
shown that the burden of other chronic diseases in patients
with more severe kidney disease is significantly higher [28].
Patients with the disease combination chronic respiratory
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disease and severe kidney disease may perceive themselves
unable to participate in PA because of the disruptive and
burdensome effect of both diseases on their daily life and
well-being. Moreover, shortness of breath caused by chronic
respiratory disease may worsen due to the additional influ-
ence of severe kidney disease. The extra fluid in the body can
accumulate in the lungs. In addition, anaemia may lead to
oxygen starvation and shortness of breath. The combination
of both diseases may also aggravate fatigue. Fatigue, defined
as the perception of mental or physical exhaustion, is a
common symptom in chronic respiratory diseases [29]. As
the kidney’s fail, they produce less erythropoietin, a hormone
that initiates the production of oxygen-carrying blood cells.
Consequently, chronic respiratory disease in combination
with fewer red blood cells carrying oxygen due to kidney
failure leads to anaemia, which causes the muscles and
brain to become exhausted very easily [28]. Besides, the
physiological explanation for low PA levels in patients who
suffer from respiratory disease and severe kidney disease
must acknowledge the low statistical power of the analysis of
this chronic disease pair (𝑁 = 10).
Moreover, patients with the chronic disease pair chronic
respiratory disease and inflammatory joint disease combined
showed extra inadequate PA levels. Previous research showed
that joint inflammation might be interrelated with chronic
respiratory disease [29]. Long-term inflammation may cause
scarring of the lungs, which in turn leads to shortness
of breath, chronic dry cough, and fatigue. Additionally,
inflammation can also cause pleural inflammation, resulting
in shortness of breath and painful respiration. The connect-
edness of both chronic diseases might increase symptom
severity, especially pain perception and breathing problems
which may in turn explain why patients with chronic respi-
ratory disease and inflammatory joint disease avoid PA and
are therefore eminently noncompliant with the Dutch PA
guideline recommendation.
Last, two chronic disease pairs that show an ancillary
inverse association with PA are rheumatoid arthritis and
inflammatory joint disease and rheumatoid arthritis and
osteoarthritis of the knees, hips, and hands. A phenomeno-
logical study conducted by Petursdottir et al. [30] identified
facilitators and barriers to exercising among people with
osteoarthritis. Patients suffering from osteoarthritis of the
knees, hips, and hands often have difficulties with PA because
of symptoms such as pain and stiffness. Furthermore, uncer-
tainty about the amount and type of exercise they require,
as well as when to expect benefits, seems to contribute
to inadequate PA levels [30]. Prior negative experiences
with overtraining resulting in increased pain levels after PA
have been found in 15% of all patients with osteoarthritis
and might contribute to PA guideline noncompliance [30].
Furthermore, it is well known that the pain levels of all
individual diseases vary from day to day. The combination
of two diseases might cause constant pain, which the patient
may perceive as too intense to engage in PA. Moreover,
perceived frailty and perceived poor health might play a role
in patients with one of these two chronic disease pairs [31].
5. Conclusions
Six chronic disease pairs were identified in which having the
combination of the two diseases leads to even more non-
compliance than expected based on the sum of the diseases
individually: chronic respiratory disease and severe back
problems; migraine and inflammatory joint disease; chronic
respiratory disease and severe kidney disease; chronic res-
piratory disease and inflammatory joint disease; inflamma-
tory joint disease and rheumatoid arthritis; and rheumatoid
arthritis and osteoarthritis of the knees, hips, and hands. The
results of the present studymay alert health care professionals
of particularly low physical activity levels in patients with one
of the six chronic disease pairs. Further research is needed
to back up our findings to test whether these results remain
stable in different patient populations.
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